Richmond A - Search Results

1

Raman D, Baugher PJ, Thu YM, Richmond A. Raman D, et al. Among authors: richmond a. Cancer Lett. 2007 Oct 28;256(2):137-65. doi: 10.1016/j.canlet.2007.05.013. Epub 2007 Jul 12. Cancer Lett. 2007. PMID: 17629396 Free PMC article. Review.

2

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins.

Owen JD, Strieter R, Burdick M, Haghnegahdar H, Nanney L, Shattuck-Brandt R, Richmond A. Owen JD, et al. Among authors: richmond a. Int J Cancer. 1997 Sep 26;73(1):94-103. doi: 10.1002/(sici)1097-0215(19970926)73:1<94::aid-ijc15>3.0.co;2-5. Int J Cancer. 1997. PMID: 9334815 Free article.

3

Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression.

Luan J, Shattuck-Brandt R, Haghnegahdar H, Owen JD, Strieter R, Burdick M, Nirodi C, Beauchamp D, Johnson KN, Richmond A. Luan J, et al. Among authors: richmond a. J Leukoc Biol. 1997 Nov;62(5):588-97. doi: 10.1002/jlb.62.5.588. J Leukoc Biol. 1997. PMID: 9365113 Free article. Review.

4

Multiple chemotactic factors: fine control or redundancy?

Devalaraja MN, Richmond A. Devalaraja MN, et al. Among authors: richmond a. Trends Pharmacol Sci. 1999 Apr;20(4):151-6. doi: 10.1016/s0165-6147(99)01342-5. Trends Pharmacol Sci. 1999. PMID: 10322500 Review.

5

Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.

Yang J, Richmond A. Yang J, et al. Among authors: richmond a. Cancer Res. 2001 Jun 15;61(12):4901-9. Cancer Res. 2001. PMID: 11406569

Constitutive IKK activity associated with increased IkappaBalpha phosphorylation and degradation contribute to the high level of endogenous nuclear factor-kappaB (NF-kappaB) activation in Hs294T melanoma cells as compared with RPE cells (R. L. Shattuck-Brandt and A. Ric …

Constitutive IKK activity associated with increased IkappaBalpha phosphorylation and degradation contribute to the high level of endogenous …

6

Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors.

Luan J, Furuta Y, Du J, Richmond A. Luan J, et al. Among authors: richmond a. Cytokine. 2001 Jun 7;14(5):253-63. doi: 10.1006/cyto.2001.0882. Cytokine. 2001. PMID: 11444905 Free PMC article.

7

Role of CXCL1 in tumorigenesis of melanoma.

Dhawan P, Richmond A. Dhawan P, et al. Among authors: richmond a. J Leukoc Biol. 2002 Jul;72(1):9-18. J Leukoc Biol. 2002. PMID: 12101257 Free PMC article. Review.

8

Nf-kappa B, chemokine gene transcription and tumour growth.

Richmond A. Richmond A. Nat Rev Immunol. 2002 Sep;2(9):664-74. doi: 10.1038/nri887. Nat Rev Immunol. 2002. PMID: 12209135 Free PMC article. Review.

9

How do chemokine/chemokine receptor activations affect tumorigenesis?

Richmond A, Fan GH, Dhawan P, Yang J. Richmond A, et al. Novartis Found Symp. 2004;256:74-89; discussion 89-91, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027484 Review.

10

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma.

Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A. Amiri KI, et al. Among authors: richmond a. Cancer Res. 2004 Jul 15;64(14):4912-8. doi: 10.1158/0008-5472.CAN-04-0673. Cancer Res. 2004. PMID: 15256463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page